Drugs / LEM
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04009577 | Jul 2019 → Mar 2020 | insomnia | Eisai Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04009577 ↗ |
| Route | Oral | “administered as a tablet, orally” NCT04009577 ↗ |